Institutional Ownership
Mineralys Therapeutics Inc
CUSIP 603170101COMMLYSQ1 2026
13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
22.4%
Max % of class reported
Institutional Holders
207
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
22 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Catalys Pacific Fund, LP | 13G/A | 10.1% | 8.00M | SEC |
| 2 | Feb 5, 2026 | Fmr LLC | 13G | 6.3% | 5.02M | SEC |
| 3 | Jan 21, 2026 | Blackrock, Inc. | 13G | 5.2% | 4.11M | SEC |
| 4 | Sep 8, 2025 | Samsara Biocapital, L.P. | 13D/A | 8.2% | — | SEC |
| 5 | Sep 8, 2025 | Ra Capital Management, L.P. | 13D/A | 9.9% | — | SEC |
| 6 | Aug 14, 2025 | Andera Partners | 13G/A | 4.2% | 2.77M | SEC |
| 7 | Aug 14, 2025 | Catalys Pacific Fund, LP | 13G/A | 13.5% | 8.98M | SEC |
| 8 | Mar 17, 2025 | Samsara Biocapital, L.P. | 13D/A | 9.1% | — | SEC |
| 9 | Mar 17, 2025 | Ra Capital Management, L.P. | 13D/A | 9.9% | — | SEC |
| 10 | Feb 14, 2025 | Adams Street Partners, LLC | 13G/A | 2.3% | — | SEC |
12 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Mineralys Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Catalys Pacific, LLC | 7.90M | $214.11M |
| 2 | Ra Capital Management, L.P. | 7.69M | $208.40M |
| 3 | Samsara Biocapital, LLC | 5.87M | $159.05M |
| 4 | Fmr LLC | 4.86M | $131.69M |
| 5 | Blackrock, Inc. | 4.48M | $121.41M |
| 6 | Wellington Management Group LLP | 3.36M | $91.00M |
| 7 | State Street Corp | 2.94M | $79.53M |
| 8 | Caligan Partners LP | 2.77M | $75.11M |
| 9 | Laurion Capital Management LP | 2.23M | $60.47M |
| 10 | Orbimed Advisors LLC | 2.05M | $55.61M |